Zobrazeno 1 - 10
of 728
pro vyhledávání: '"Wichmann Ole"'
Autor:
Griskaitis, Matas, Thielemann, Iris, Schönfeld, Viktoria, Falman, Annika, Scholz, Stefan, Reinacher, Ulrich, Haas, Laura, Wichmann, Ole, Harder, Thomas
Publikováno v:
In Journal of Infection September 2024 89(3)
Autor:
Salo, Heini, Sakalauskaitè, Milda, Lévy-Bruhl, Daniel, Lindstrand, Ann, Valentiner-Branth, Palle, Wichmann, Ole, Puumalainen, Taneli
Publikováno v:
In Vaccine: X December 2023 15
Autor:
Böhmer Merle M, Walter Dietmar, Falkenhorst Gerhard, Müters Stephan, Krause Gérard, Wichmann Ole
Publikováno v:
BMC Public Health, Vol 12, Iss 1, p 938 (2012)
Abstract Background In Germany, annual vaccination against seasonal influenza is recommended for certain target groups (e.g. persons aged ≥60 years, chronically ill persons, healthcare workers (HCW)). In season 2009/10, vaccination against pandemic
Externí odkaz:
https://doaj.org/article/cea94f75e1fd4dad97624529f68e3b75
Autor:
Hellenbrand Wiebke, Jorgensen Pernille, Schweiger Brunhilde, Falkenhorst Gerhard, Nachtnebel Matthias, Greutélaers Benedikt, Traeder Christian, Wichmann Ole
Publikováno v:
BMC Infectious Diseases, Vol 12, Iss 1, p 127 (2012)
Abstract Background We performed a case–control study to estimate vaccine effectiveness (VE) for prevention of hospitalization due to pandemic influenza A(H1N1)pdm09 (pH1N1) and to identify risk factors for pH1N1 and acute respiratory infection (AR
Externí odkaz:
https://doaj.org/article/18aadbf25cc345d4b38524e2bd006250
Autor:
Nachtnebel Matthias, Greutelaers Benedikt, Falkenhorst Gerhard, Jorgensen Pernille, Dehnert Manuel, Schweiger Brunhilde, Träder Christian, Buda Silke, Eckmanns Tim, Wichmann Ole, Hellenbrand Wiebke
Publikováno v:
BMC Public Health, Vol 12, Iss 1, p 245 (2012)
Abstract Background Surveillance of severe acute respiratory infections (SARI) in sentinel hospitals is recommended to estimate the burden of severe influenza-cases. Therefore, we monitored patients admitted with respiratory infections (RI) in 9 Berl
Externí odkaz:
https://doaj.org/article/934bb502b8a94e24b5c6af3a07a63287
Autor:
Reinhold Thomas, Rieck Thorsten, Siedler Anette, Ultsch Bernhard, Krause Gérard, Wichmann Ole
Publikováno v:
BMC Infectious Diseases, Vol 11, Iss 1, p 173 (2011)
Abstract Background Herpes zoster (HZ) is caused by a reactivation of the varicella-zoster-virus (VZV) and mainly affects individuals aged ≥ 50 years. Vaccines have been licensed or are under development that can protect against HZ and its main com
Externí odkaz:
https://doaj.org/article/a492bbfe723a4544bc1b52d0cfcd5a93
Autor:
Margolis Harold S, Duong Socheat, Ngan Chantha, Beatty Mark, Wichmann Ole, Huy Rekol, Vong Sirenda
Publikováno v:
BMC Public Health, Vol 9, Iss 1, p 155 (2009)
Abstract Background The average annual reported dengue incidence in Cambodia is 3.3/1,000 among children < 15 years of age (2002–2007). To estimate the economic burden of dengue, accurate cost-of-illness data are essential. We conducted a prospecti
Externí odkaz:
https://doaj.org/article/a9ca1071fedc49308e0400d1c515be4a
Autor:
Frank Christina, Niedrig Matthias, Stark Klaus, Shu Pei-Yun, Wichmann Ole, Huang Jyh-Hsiung, Jelinek Tomas
Publikováno v:
BMC Infectious Diseases, Vol 6, Iss 1, p 120 (2006)
Abstract Background Several enzyme-linked immunosorbent assay (ELISA)-kits are commercially available for the rapid diagnosis of dengue infection, and have demonstrated good sensitivity and specificity in paired serum samples. In practice, however, o
Externí odkaz:
https://doaj.org/article/4212dc106789416a94c53b381792b85f
Autor:
Piechotta, Vanessa *, *, Siemens, Waldemar *, Thielemann, Iris, Toews, Markus, Koch, Judith, Vygen-Bonnet, Sabine, Kothari, Kavita, Grummich, Kathrin, Braun, Cordula, Kapp, Philipp, Labonté, Valérie, Wichmann, Ole, Meerpohl, Joerg J, Harder, Thomas
Publikováno v:
In The Lancet Child & Adolescent Health June 2023 7(6):379-391
Autor:
Mockenhaupt Frank P, Gruss Holger, Muehlen Marion, Wichmann Ole, Suttorp Norbert, Jelinek Tomas
Publikováno v:
Malaria Journal, Vol 3, Iss 1, p 14 (2004)
Abstract Malarone® (atovaquone-proguanil) is an effective drug for the treatment and prophylaxis of multidrug-resistant falciparum malaria. However, first cases of resistance have been reported, which are associated with mutations at codon 268 of th
Externí odkaz:
https://doaj.org/article/e9bbd17f350e41c0930fe0365ed1688a